Neuren Pharmaceuticals Ltd (NEU) — Long-term Investment Intensity
Neuren Pharmaceuticals Ltd (NEU) has a Long-term Investment Intensity of 7.7% as of December 2017. Long-term investments of AU$1.37 Million represent 7.7% of total assets of AU$17.94 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Neuren Pharmaceuticals Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Neuren Pharmaceuticals Ltd Long-term Investment Intensity (2017–2017)
This chart shows how Neuren Pharmaceuticals Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2017 to 2017. As of December 2017, the intensity stands at 7.7%, reflecting long-term investments of AU$1.37 Million against total assets of AU$17.94 Million AUD. Explore Neuren Pharmaceuticals Ltd (NEU) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Neuren Pharmaceuticals Ltd (2017–2017)
The table below presents the year-by-year Long-term Investment Intensity for Neuren Pharmaceuticals Ltd from 2017 to 2017, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Neuren Pharmaceuticals Ltd worth.
| Year | LT Investment Intensity | LT Investments (AUD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 7.7% | AU$1.37 Million | AU$17.94 Million | — |